119 related articles for article (PubMed ID: 8187396)
1. Antigranulocyte antibody bone marrow scans in cancer patients with metastatic bone superscan appearance.
Berná L; Torres G; Carrió I; Estorch M; Germá JR; Alonso C
Clin Nucl Med; 1994 Feb; 19(2):121-8. PubMed ID: 8187396
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
3. Antigranulocyte bone marrow scans in Paget's disease.
Torres G; Berná L; Carrió I; Estorch M; Díaz C; Farrerons J
Clin Nucl Med; 1994 Aug; 19(8):671-4. PubMed ID: 7955742
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS
J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
[TBL] [Abstract][Full Text] [Related]
5. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer.
Duncker CM; Carrió I; Berná L; Estorch M; Alonso C; Ojeda B; Blanco R; Germá JR; Ortega V
J Nucl Med; 1990 Sep; 31(9):1450-5. PubMed ID: 2168473
[TBL] [Abstract][Full Text] [Related]
6. Intraindividual Comparison of
Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow imaging of bone marrow transplanted multiple myeloma patients.
Agren B; Rudberg U; Måre K; Aspelin P
Clin Nucl Med; 1997 Feb; 22(2):80-92. PubMed ID: 9031764
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
[TBL] [Abstract][Full Text] [Related]
9. Improved diagnosis of advanced bone marrow metastases by means of radiolabeled antigranulocyte antibodies.
von Mallek D; Joe A; Palmedo H; Matthies A; Biersack HJ; Reinhardt MJ
J Exp Clin Cancer Res; 2002 Sep; 21(3):421-4. PubMed ID: 12385588
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
Zoeller G; Sandrock D; Munz DL; Ringert RH
Eur Urol; 1994; 26(2):141-4. PubMed ID: 7957469
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.
Otsuka N; Fukunaga M; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A; Morita R
Eur J Nucl Med; 1985; 11(8):319-22. PubMed ID: 4076240
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
Ivancevic V; Huic D; Wolter A; Munz DL
Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m labelled anti CD 66 antigranulocyte antibody imaging for assessment of bone marrow reserve.
Matthies A; Reinhardt M; Palmedo H; Ezziddin S; Abramowski B; Kuhn W; Biersack HJ; von Mallek D
Cancer Invest; 2005; 23(2):119-22. PubMed ID: 15813503
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders.
Chung JK; Yeo J; Lee DS; Park S; Lee MC; Kim BK; Koh CS
J Nucl Med; 1996 Jun; 37(6):978-82. PubMed ID: 8683326
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy of the bone marrow: normal uptake values of technetium-99m-labeled monoclonal antigranulocyte antibodies.
Huić D; Ivancević V; Richter WS; Munz DL
J Nucl Med; 1997 Nov; 38(11):1755-8. PubMed ID: 9374347
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
[TBL] [Abstract][Full Text] [Related]
18. [Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow].
Reske SN; Karstens JH; Henrich MM; Sohn M; Glöckner W; Jakse G; Büll U
Nuklearmedizin; 1993 Jun; 32(3):111-9. PubMed ID: 8327329
[TBL] [Abstract][Full Text] [Related]
19. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy.
Yüksel D; Ilgan S; Arslan N; Uğur O; Oztürk E; Bayhan H
Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416
[TBL] [Abstract][Full Text] [Related]
20. Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma.
Balaban EP; Walker BS; Cox JV; Sein AA; Abrams PG; Salk D; Sheehan RG; Frenkel EP
Clin Nucl Med; 1991 Oct; 16(10):732-6. PubMed ID: 1660386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
